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Highlights: 
 
 Human endothelial cells were cultured with different concentrations of linoleic acid, alpha-linolenic 
acid and ratios of these fatty acids followed by TNF-α stimulation.  
 
 A low linoleic acid to alpha-linolenic acid ratio may lower the production of inflammatory mediators 
 
 The anti-inflammatory effects were likely mediated by alpha-linolenic acid 
 
 Linoleic acid was not found to exert pro-inflammatory effects, but may even possess some anti-
inflammatory properties.  
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Abstract 
Alpha-linolenic acid (ALA) and linoleic acid (LA) are precursors for longer-chain more unsaturated 
fatty acids and for lipid signaling molecules that may influence inflammatory processes through a 
variety of mechanisms. The actions of LA and ALA may be divergent and interdependent. The aim 
of this study was to investigate the incorporation and metabolism of ALA and LA in cultured in 
EA.hy926 endothelial cells and the production of inflammatory mediators (VEGF, RANTES, 
ICAM-1, MCP-1, IL-6 and IL-8) by these cells when exposed to different concentrations of ALA, 
LA and ratios of LA:ALA. Human endothelial cells were cultured with either culture medium or 
culture medium supplemented with ALA, LA or various ratios of LA:ALA (1:4, 1:1, 4:1, 9:1 or 
19:1) followed by 24 hour TNF-α stimulation; the total concentration of ALA plus LA was kept 
constant at 100 μM. The incorporation and metabolism of ALA and LA was measured using gas 
chromatography. The production of inflammatory mediators in the supernatant was assessed using a 
Luminex Multi-Analyte kit. Both ALA and LA were incorporated and metabolised by the endothelial 
cells. Cells incubated with ALA had a statistically significantly lower production of VEGF, RANTES, 
ICAM-1, MCP-1 and IL-6 compared to cells incubated without additional ALA. LA was not found 
to exert pro-inflammatory effects. Cells incubated with low LA:ALA ratios had lower production of 
VEGF, RANTES, MCP-1 and IL-6 when compared with a LA:ALA ratio of 19:1. These findings 
suggest that a low LA:ALA ratio exerts anti-inflammatory effects by lowering the production 
VEGF, RANTES, ICAM-1, MCP-1 and IL-6 in TNF-α stimulated endothelial cells compared to a 
high ratio. These effects were likely mediated by ALA, but LA may also possess some anti-
inflammatory effects.  
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Introduction 
Vascular endothelial cells play important roles in atherosclerosis and other inflammatory processes 
through controlling adhesion and transendothelial migration of circulating immune cells [1,2]. 
Lowering the production of inflammatory mediators by endothelial cells may be a potential target to 
inhibit the atherosclerotic process.  
Polyunsaturated fatty acids (PUFAs) act through a variety of mechanisms to affect inflammatory  
processes [3,4]. However, the effects of different PUFAs on these processes may be divergent and 
interdependent. Long-chain PUFAs such as arachidonic acid (AA), eicosapentaenoic acid (EPA) 
and docosahexaenoic acid (DHA) have been well explored in the context of inflammation [5,6]. 
Other PUFAs are less well studied. The plant-derived n-3 PUFA alpha-linolenic acid (ALA), and 
the n-6 PUFA linoleic acid (LA) are both precursors for further desaturation and elongation that 
occurs by shared enzymes in a complex biological pathway. ALA may be converted into LC n-3 
PUFAs including EPA, docosapentaenoic acid (DPA) and DHA, while LA can be converted to AA 
and beyond [7]. The conversion of ALA into LC n-3 PUFAs may be important for the physiological 
effects of ALA [7]. Although the conversion efficiency may be limited in humans [8], ALA may 
constitute an alternative and important source of LC n-3 PUFAs given the greater availability of 
sources rich in ALA such as walnuts, flaxseed, green leafy vegetables and plant oils including 
canola and soybean oils [9] compared to marine-derived LC n-3 PUFAs. Most Western diets 
contain an excess of LA over ALA [7]. Lowering the ratio of LA to ALA is likely to favour 
synthesis of EPA [7]. 
The first step of the pathway of LA and ALA conversion is catalysed by a Δ6-desaturase, which  
is considered to be the rate-limiting step in the reaction [10]. No interconversion occurs between the 
n-3 PUFA and n-6 PUFA families, but competition between ALA and LA may occur and includes 
both substrate competition and product inhibition [11–16]. In addition, previous studies have 
suggested that the Δ6-desaturase may have a higher substrate preference for ALA than LA [16–19]. 
However, the importance of such preference is uncertain because the intake of LA in most 
populations by far exceeds that of ALA [7].  
LC n-3 PUFAs may exert inhibitory effects on inflammation by reducing leucocyte  
chemotaxis, adhesion molecule expression and leukocyte-endothelial adhesive interactions, and 
production of pro-inflammatory cytokines and of pro-inflammatory eicosanoids from AA [4,5]. 
They also promote increased production of inflammation-resolving mediators including resolvins, 
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protectins and maresins [4,5]. However, LC n-3 PUFAs do also give rise to inflammatory 
eicosanoids, but these are considered less inflammatory compared to those produced from AA [4,5]. 
The suggested competitive mechanisms between ALA and LA imply that lower ratios of  
LA:ALA may be associated with a higher conversion efficiency of ALA and a lower production of 
inflammatory mediators when compared to higher ratios. The effect of changing the ratio of LA to 
ALA on inflammatory responses has been little studied. Therefore, the objectives of this study were 
to investigate the incorporation and metabolism of ALA and LA in cultured endothelial cells and to 
explore the production of inflammatory mediators by these cells when exposed to different 
concentrations of ALA, LA and ratios of LA:ALA. 
 
Materials and methods 
 
Cell culture conditions and study design 
The human hybrid endothelial cell line EA.hy926 (ATCC
®
 CRL-2922
TM
) was obtained from 
ATCC. The cells were thawed and subcultured in accordance with the suppliers’ instructions. Cells 
were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal 
bovine serum (Sigma-Aldrich), 1% L-glutamine, penicillin and streptomycin solution and HAT 
Media Supplement (100 μM hypoxanthine, 0.4 μM aminopterin, 16 μM thymidine, Hybri-Max
TM
, 
Sigma-Aldrich). Prior to the experiments, cells were cultured in Corning T-175 culture flasks at 
37
o
C in 5% CO2 until cells were confluent.  
ALA and LA were obtained from Sigma-Aldrich. Prior to the experimental procedures master stock 
concentrations of these fatty acids was verified using gas chromatography analyses. The fatty acids 
were dissolved in 100% ethanol. Subsequently, the fatty acids were diluted in DMEM to obtain 
final exposure concentrations of a total of 100 μM in 0.1% ethanol. Fatty acid treatments were as 
follows; 100 μM ALA, 100 μM LA and different ratios of LA:ALA: 1:4 (20 μM LA : 80 μM ALA), 
R1:1 (50 μM LA : 50 μM ALA), R4:1 (80 μM LA : 20 μM ALA), R9:1 (90 μM LA : 10 μM ALA) 
or R19:1 (95 μM LA : 5 μM ALA). In experiments evaluating potential competition between ALA 
and LA, we used a constant exposure concentration of 50 μM ALA with increasing amounts of LA 
(10 μM, 25 μM, 50 μM and 75 μM).  
The incorporation and metabolism of ALA and LA were investigated by scraping and  
resuspending confluent endothelial cells at a density of 3.6 x10
5
 cells/ml for culturing with either 
culture medium or culture medium supplemented with fatty acids corresponding to the exposure 
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concentrations described above. Cells were seeded at 9 x10
5
 cells per T-25 culture flask and 
incubated for 48 hours at 37
o
C in 5% CO2. Following incubation, cells were scraped, centrifuged at 
1200 rpm for 5 minutes and resuspended in unsupplemented DMEM for cell counting using a 
Beckman Coulter cell counter. Subsequently, the cells were centrifuged at 1200 rpm for 5 minutes 
and the pellet was resuspended in 0.9% NaCl to obtain a concentration of 1.25x10
6
 cells. The 
experiments were conducted in duplicates and repeated three times (3 independent experiments). 
The production of inflammatory mediators was explored by culturing endothelial cells  
with either culture medium with supplements or culture medium with supplements and fatty acids 
described above for 48 hours followed by 24 hours stimulation with TNF-α (1 ng/ml). Initially, 
confluent endothelial cells were scraped from culture flasks and resuspended in supplemented 
DMEM at a density of 2x10
5
 cells/ml based on cell counts using a Beckman Coulter cell counter. 
The cells were seeded at 1x10
4
 cells/well in a 96-well bottom flat plate. Following incubation, 
supernatant was removed and stored below -20
o
C until analysis. These experiments were conducted 
in triplicates and repeated three times (3 independent experiments). 
 
Lipid extraction and fatty acid analysis 
The fatty acid composition of the endothelial cells was determined using gas chromatography. Total 
lipid was extracted from the resuspended cell pellets of which 800 μl was transferred to glass tubes 
with 30 μl of internal standard (1 μg/μl 37 FAMES). Subsequently, 5.0 ml chloroform:methanol 
(2:1) containing butylated hydroxytoluene (50 mg/l) as anti-oxidant was added followed by 1.0 mL 
1 M NaCl. The samples were vortexed and centrifuged at 2000 rpm for 10 minutes. The lower 
phase was collected from each sample using Pasteur pipettes and transferred to glass tubes which 
were dried under nitrogen at 40
o
C. Then, 0.5 ml dry toluene and 1.0 ml methanol containing 2% 
(v/v) H2SO4 were added to each sample followed by heating at 50
o
C for 2 hours. Samples were 
allowed to cool and 1.0 ml of neutralizing solution (0.25 M KHCO3 (25.03 g/l) and 0.5 M K2CO3 
(69.10 g/l)) was added. Subsequently, 1.0 ml dry hexane was added and the samples were 
centrifuged at 1000 rpm for 2 minutes. The upper phase was collected using Pasteur pipettes and 
dried under nitrogen. Samples were resuspended in 150 μl dry hexane and transferred to a gas 
chromatograph autosampler vial. The fatty acid analyses were performed using a Hewlett-Packard 
6890 chromatograph. A SGE BPX-70 capillary column (30 m x 0.2 mm x 0.25 µm) and 
temperature programming were used (115
o
C for 2 min, then increased by 10ºC every minute until 
reaching 200ºC which was held for a further 18 minutes). The injector port temperature was 300
o
C 
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and the split ratio 2:1. Helium was used the carrier gas. Chromatograms were analysed using 
Agilent ChemStation software. Fatty acid concentrations were expressed in μg per 10
6 
cells. 
 
Assessment of inflammatory mediators  
The concentrations of the inflammatory mediators including interleukin 6 (IL-6), interleukin 8 (IL-
8), vascular endothelial growth factor (VEGF), monocyte chemoattractant protein-1 (MCP-1), 
regulated on activation, normal T cell expressed and secreted (RANTES) and intercellular adhesion 
molecule-1 (ICAM-1) were determined using a purchased premixed Human Luminex Multi-
Analyte kit (R&D Systems Europe, Ltd). Reagents and standards were prepared in accordance with 
the instructions from the manufacturer. Plates were analysed on a calibrated Luminex® 200 reader 
using Bio-Plex software (version 6.1, Bio-Rad Laboratories Inc. United States). Lower limits of 
detection are: IL-6 (1.7 pg/mL), IL-8 (1.8 pg/mL), VEGF (2.1 pg/mL), M P-1 (9.9 pg/mL), 
RANTES (1.8 pg/mL) and ICAM-1 (87.9 pg/mL). 
 
Evaluation of cell viability 
Cell viability was evaluated as mitochondrial activity using a quantitative colorimetric assay. 
Confluent cells were scraped and resuspended at a density of 2x10
5
 cells/ml. The cells were then 
seeded at 1x10
4
 cells/well in a 96-well bottom flat plate. The cells were incubated for 48 hours with 
the various fatty acid exposure concentrations as described previously, followed by 24hour 
incubation with TNF-α (1 ng/ml). These experiments were conducted in triplicates and repeated 
three times (n = 9). Following, the medium was replaced by 3-(4,5-dimethylthiazolyl-2)-2,5-
diphenyltetrazolium bromide (5mg/mL) (Sigma-Aldrich) in DMEM (100 μl/well) and incubated for 
4hours. After incubation, 75 μl supernatant was replaced by 75 μl DMSO added to each well. The 
plates were incubated for a further 10 minutes. Absorbance was measured at 540 nm on a plate 
reader. The absorbance in DMEM controls was set at 100%.  
 
Statistical analyses 
We used multiple linear regression to calculate the average mean difference across experiments in 
the PUFA content and the production of inflammatory mediators with 95% confidence intervals 
(CIs). In analyses of either ALA or LA alone, we used DMEM as reference. In analyses of the 
different ratios of LA:ALA the highest ratio (R19) was used as reference, whereas in analyses 
evaluating effects of adding increasing LA amounts to a constant ALA concentration, we used ALA 
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alone as reference. In analyses of cell viability we used DMEM control as reference. Model 
assumptions of normality and variance homogeneity of the observations were assessed visually by 
inspection of residual plots. Further, the assumption of variance homogeneity was formally tested 
using robust tests for the equality of variances. In sensitivity analyses and when assumptions were 
not met, we used robust variance estimation based on bootstrap analyses with 5000 replicates to 
calculate CI intervals and P-values. Data were analyzed using Stata statistical software (version 14; 
StataCorp MP), and P-values below 0.05 was considered statistically significant. Graphs were 
prepared using GraphPad Prism 7.0 (GraphPad Software, La Jolla California USA). 
 
Results 
 
Incorporation and metabolism of PUFAs 
In cells incubated with either 100 μM of ALA or LA alone, the absolute content of these PUFAs 
was statistically significantly higher than in cells incubated with DMEM. Also, the absolute content 
of ALA increased in a dose-dependent manner with lower ratios of LA:ALA although only 
statistically significantly when comparing the lowest ratios (4:1, 1:1 and 4:1) with the highest (19:1) 
(Figure 1A and Supplemental Table 1). The content of LA decreased with lower LA:ALA ratios 
although only statistically significantly when comparing the lowest ratio with the highest. In cells 
incubated with 100 μM of ALA, the content the longer-chain metabolites ETA, EPA and DPA 
increased, whereas the content of DHA decreased when comparing with cells cultured in DMEM. 
Across ratios of LA:ALA, the content of DPA increased significantly with lower ratios. Also, the 
content of EPA increased slightly although not statistically significantly. No appreciable differences 
were observed across ratios for ETA (Figure 1B and Supplemental Table 1). Stearidonic acid could 
not be identified in any of the samples. In cells exposed to 100 μM of LA, the contents of GLA and 
AA were lower, whereas the content of DGLA was higher compared cells cultured in DMEM. In 
cells exposed to the lowest ratio of LA:ALA, there were lower concentrations of DGLA and AA 
compared cells cultured with the highest ratio of LA:ALA. No appreciable differences in the 
content of GLA were seen across ratios of LA:ALA (Figure 1C and Supplemental Table 1).  
When cells incubated with 50 μM ALA and varying concentrations of LA, we found that cells  
incubated with both ALA and LA had significantly lower incorporation of ALA compared to cells 
incubated with 50 μM ALA alone. However, the incorporation did not seem to decrease with 
increasing exposure to LA (Figure 2 and Supplemental Table 2). The content of the longer-chain 
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metabolites EPA and DPA was lower in cells incubated with both ALA and LA compared to 50 μM 
ALA alone although this was only statistically significant for EPA.  
 
Inflammatory mediators 
The concentrations of VEGF, RANTES, ICAM-1, MCP-1 and IL-6 were statistically significantly 
lower in the medium of cells incubated with 100 μM ALA when comparing with TNF-α stimulated 
control cells cultured in DMEM (Figure 3 and Supplemental Table 3). No statistically significant 
difference was found for IL-8 in cells incubated with 100 μM ALA. In cells incubated with 100 μM 
LA, there were statistically significantly lower concentrations of RANTES and MCP-1 in the 
medium compared with cells incubated with DMEM control. Also, a slight, but not statistically 
significant, lower concentration of ICAM-I was found in the medium of cells incubated with 100 
μM LA. When evaluating different ratios of LA:ALA, the concentrations of VEGF, RANTES, 
MCP-1 and IL-6 decreased with lower ratios when comparing with the highest ratio. However, the 
observed lower concentrations of VEGF, MCP-1 and IL-6 were only statistically significant for the 
two lowest ratios (1:4 and 1:1) when comparing with the highest. Also, the concentration of ICAM-
1 was only statistically significantly lower for the lowest ratio compared with the highest. No 
appreciable nor consistent pattern was observed across ratios for IL-8 concentration.  
In cells incubated with either 50 μM ALA or LA, there were statistically significantly lower 
concentrations of VEGF, RANTES, ICAM-1, MCP-1 and IL-6, whereas no appreciable differences 
were seen for IL-8, when comparing with cells incubated in DMEM. In cells incubated with 50 μM 
ALA and varying concentrations of LA, the concentrations of VEGF, RANTES, ICAM-1 and IL-6 
decreased slightly with increasing LA concentrations, but these differences were only statistically 
significant when comparing cells incubated with 50 μM ALA and the two highest LA 
concentrations (50 μM and 75 μM) (Figure 4 and Supplemental Table 4).  
 
Cell viability 
Cells incubated with LA alone (50 μM or 100 μM) had a moderately lower viability than cells 
incubated with DMEM although only statistically significantly so for cells incubated with the 
lowest LA concentration (50 μM) (Figure 5). Cells incubated with ALA (50 μM or 100 μM) alone 
had an approximately 20% lower viability than cells incubated with DMEM alone although only 
statistically significantly so for cells incubated with 50 μM ALA. Cells incubated with a LA:ALA 
ratio of 1:1 had an statistically significantly lower viability, whereas no discernible differences in 
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viability were at LA:ALA ratios of 1:4, 4:1, 9:1 and 19:1, respectively (Figure 5A). However, cells 
incubated either 10 μM, 25 μM, 50 μM or 75 μM LA in addition to 50 μM ALA had a statistically 
significant lower viability compared to cells incubated with DMEM of approximately 25% (Figure 
5B).  
 
Discussion 
In this in vitro study, we found that TNF-α stimulated endothelial cells preincubated with low 
LA:ALA ratios had a lower production of VEGF, RANTES, MCP-1 and IL-6 compared to cells 
preincubated with a high LA:ALA ratio. The observed anti-inflammatory effects were likely to be a 
result of increased ALA exposure because endothelial cells preincubated with ALA alone had a 
lower production of the same cytokines compared to DMEM controls, whereas much less of an 
effect was seen in cells incubated with LA alone. However, LA seemed to lower the production of 
RANTES and MCP-1. Interestingly, the production of VEGF, RANTES, MCP-1 and IL-6 also 
seemed to decrease in endothelial cells incubated with increasing LA concentrations while ALA 
exposure was kept constant. This suggests that LA may have some anti-inflammatory effects, which 
is in contrast to concerns raised about potential pro-inflammatory properties of LA possibly due to 
its role as a precursor of AA, which may be converted to a variety of potent pro-inflammatory 
prostaglandins and leukotrienes [20]. However, a recent review concluded that the current evidence 
does not support that dietary intake nor plasma levels of LA appear to result in increased tissue AA 
or in increased in vivo or ex vivo concentrations of inflammatory markers in humans [6]. In this 
study, we found that both ALA and LA were incorporated into the cells in a dose-dependent pattern, 
but no appreciable differences were seen in the content of AA in the cells across ratios of LA:ALA. 
However, the content of AA was markedly lower in cells incubated with LA, ALA and ratios of 
LA:ALA compared to DMEM control. In endothelial cells incubated with ALA alone, we found 
higher contents of ETA, EPA and DPA compared to DMEM control suggesting that ALA is 
metabolised into these longer-chain PUFAs, whereas no discernible differences were seen across 
ratios of LA:ALA, which could indicate competition from LA on ALA metabolism. This was 
supported by our findings that the content of ETA increased while EPA decreased slightly when 
higher concentrations of LA were applied to the cells exposed to constant ALA concentrations 
although these differences were not statistically significant. We do not have a clear explanation for 
the observed finding that the content of DPA, but not EPA or DHA, seemed to increase when 
lowering the LA:ALA ratio. In humans, the conversion of PUFAs occurs predominantly in the liver 
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[7] and a study has suggested that the conversion of ALA is influenced by the absolute intake of 
ALA and LA and not by their ratio [21].  
The dietary intake of LA has increased markedly throughout the last decades and the balance  
between n-6 and n-3 PUFAs has been fiercely debated in relation to cardiovascular disease (CVD) 
risk because of the suggested divergent effects of these PUFAs families on inflammation [22]. 
Thus, a balance between n-6 and n-3 PUFAs has been suggested. Substantial variations in the 
dietary LA:ALA ratio exist among different countries [7], but several western countries have 
LA:ALA ratios of 15-20 [7,23]. Lowering the n-6:n-3 PUFA ratio in the diet has been suggested to 
be a better predictor of CVD than the absolute intakes of n-3 and n-6 PUFAs [23] although this 
hypothesis has never been proven or disproven conclusively [24]. Inflammation plays a crucial role 
in the pathogenesis of atherosclerotic cardiovascular disease [1] and several studies have suggested 
that n-3 and n-6 PUFAs may influence inflammatory processes through a variety of mechanisms 
[3,5]. In contrast, limited knowledge exists on the underlying biological effects on inflammatory 
processes when cells are exposed to a combination of PUFAs. However, a recent study by Yang et 
al. examined various LA:ALA ratios (1:1, 5:1,10:1 and 20:1) on markers of inflammation, oxidative 
stress and cell function in endothelial cells and found no appreciable differences in IL-6 and TNF-α 
concentrations across ratios of LA:ALA in unstimulated cells [25]. In contrast, a previous animal 
study found that rats fed a high-fat diet based on plant oils with resulting in a low n-6:n-3 PUFA 
ratio (1:1 and 5:1) had lower serum levels of IL-6, TNF-α and C-reactive protein (CRP) compared 
with rats fed with a high n-6:n-3 PUFA ratio (20:1) diet [26]. Another study found that rats fed ad 
libitum diet with an n-3:n-6 PUFA ratio of 1:1 based on plant oils had lower levels of IL-6, TNF-α 
and CRP compared to control rats fed a diet high in saturated fatty acids (controls), whereas only 
TNF-α was found to be statistically significantly lower in rats fed with a n-3:n-6 PUFA ratio of 1:4 
compared to control rats [27]. The authors did not formally compare the two PUFA diets, but the 
levels of IL-6, TNF-α and CRP seemed to be lower in rats fed an diet with n-3:n-6 PUFA ratio of 
1:1 compared with those fed an n-3:n-6 PUFA ratio of 1:4 [27]. A study in pigs fed with different 
plant oils to obtain different dietary n-6:n-3 PUFA ratios (1:1, 10:1 and 20:1) found that the lowest 
ratio resulted in lower levels of IL-6 and IL-β compared to those fed diets with higher ratios (2.5:1, 
5:1 and 10:1) [28]. Hintze et al. [29] suggested that the total amount of PUFAs derived from plants 
may inhibit the LPS-induced acute inflammatory response, whereas the n-6:n-3 PUFA ratio may 
only be important at higher concentrations of total PUFAs. Importantly, these animal feeding 
studies were based on supplemental foods, which may provide many nutrients that could influence 
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inflammatory mediators. Also, the interpretational complexity of a ratio measure makes direct 
comparisons difficult. Using ratios of fatty acids may be an appealing approach under controlled 
conditions especially when effects of the numerator and denominator are assumed to be in opposite 
directions and interdependent. However, this metric should not stand alone and the independent 
effects the fatty acids under study should also be evaluated. Furthermore, adding combinations of 
PUFAs by increasing the concentrations of one while keeping another constant may provide some 
additional insight into the interplay between PUFAs.  
Endothelial cells play a pivotal role in the initiation and progression of atherosclerosis  
through leukocyte recruitment, expression of adhesion molecules and mediating migration of 
leukocytes into the intima [30]. In this study, we selected a number of inflammatory mediators 
believed to be important for the inflammatory response that underlies the atherosclerotic process. 
ICAM-1 is an adhesion molecule belonging to the immunoglobulin superfamily, which is expressed 
on endothelial cells and involved in leukocyte-endothelium interactions [31]. MCP-1, RANTES and 
IL-8 are chemoattractants involved in the chemotaxis of leukocytes and migration into the sub-
endothelial layer [30]. IL-6 is a cytokine with pleiotropic effects on regulation of the immune 
response, acute phase response and inflammation [32]. VEGF is involved in angiogenesis, 
proliferation of endothelial cells, and regulating vascular permeability and migration of monocytes 
[33]. We used an inflammatory cell model to investigate the interplay between LA and ALA in 
vitro. However, extrapolation of these study findings into an in vivo situation should be done with 
caution and further studies are warranted to explore the effects of combinations of fatty acids on 
inflammation. 
In conclusion, this study suggests that a low LA:ALA ratio exerts anti-inflammatory effects by  
lowering the production VEGF, RANTES, ICAM-1, MCP-1 and IL-6 in TNF-α stimulated 
endothelial cells compared to a high ratio, which was likely to be mediated by a higher ALA 
exposure rather than a lower LA exposure. This study also suggests that LA is not pro-inflammatory 
in this cell model of endothelial inflammation and may even possess some anti-inflammatory 
properties.  
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Fig. 1. Incorporation of LA and ALA (A) and appearance of n-3 (B) and n-6 elongation (C) 
productions in EA.hy926 cells incubated for 48 hours with LA, ALA and different ratios of 
LA/ALA. Concentrations are given in means with corresponding standard errors of mean. The 
experiments were conducted in duplicates and repeated three times (3 independent experiments). 
LA (100 μM) and ALA (100 μM) alone were compared with DMEM, whereas ratios (R) of 
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LA/ALA including ratio 1:4 (20:80 μM), 1:1 (50:50 μM), 4:1 (80:20 μM) and 9:1 (90:10 μM) were 
compared with the highest ratio (19:1, 95:5 μM). Statistically significant differences (p < 0.05) is 
marked by (*).  
 
 
Fig. 2. Incorporation of ALA (A) and appearance of elongation products (B) in EA.hy926 cells 
incubated with 50 μM ALA and LA concentrations of 10 μM, 25 μM, 50 μM and 75 μM, 
respectively. Concentrations are given in means with corresponding standard errors of mean. The 
experiments were conducted in duplicates and repeated three times (3 independent experiments). 
ALA 50 μM was used as reference. Statistically significant differences (p < 0.05) is marked by (*).  
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Fig. 3. Concentrations of inflammatory mediators including VEGF (A), RANTES (B), ICAM-1 
(C), MCP-1 (D), IL-6 (E) and IL-8 (F) in supernatant of EA.hy926 cells incubated for 48 hours with 
LA, ALA or different ratios of LA/ALA followed by 24 hours TNF-α stimulation. Concentrations 
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are given as means with corresponding standard errors of mean. The experiments were conducted in 
triplicates and repeated three times (3 independent experiments). LA (100 μM) and ALA (100 μM) 
alone were compared with DMEM, whereas ratios of LA:ALA including ratio 1:4, 1:1, 4:1 and 9:1 
were compared with the highest ratio (19:1). 
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Fig. 4. Concentrations of inflammatory mediators including VEGF (A), RANTES (B), ICAM-1 
(C), MCP-1 (D), IL-6 (E) and IL-8 (F) in supernatant of EA.hy926 cells incubated for 48 hours with 
50 μM ALA and varying LA concentrations (10 μM, 25 μM, 50 μM and 75 μM) followed by 24 
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hours TNF-α stimulation. Concentrations are given in means with corresponding standard errors of 
mean. The experiments were conducted in triplicates and repeated three times (3 independent 
experiments) 
 
 
Fig. 5. Cells viability of EA.hy926 cells incubated for 48 hours with (A) 100 μM LA, 100 μM ALA 
or various ratios of LA:ALA or (B) 50 μM LA, 50 μM ALA or various LA concentrations in 
addition to 50 μM ALA followed by 24 hours TNF-α stimulation. Cell viability are given in 
percentages with corresponding standard errors of mean. The experiments were conducted in 
triplicates and repeated three times (3 independent experiments). Standard errors were calculate 
based on bootstrap analyses with 5000 replications. Cells incubated with DMEM was used as 
reference. 
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